CLINICAL AND PHARMACOLOGICAL PROBLEMS OF DEPRENYL (SELEGILINE) TREATMENT IN PARKINSONS-DISEASE

被引：23

作者：

STERN, GM

LEES, AJ

HARDIE, RJ

SANDLER, M

机构：

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1983年 / 68卷

关键词：

D O I：

10.1111/j.1600-0404.1983.tb01524.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：113 / 116

页数：4

共 13 条

[1] POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].

BIRKMAYER, W ;

RIEDERER, P ;

YOUDIM, MBH ;

LINAUER, W .

JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326

[2]

BIRKMAYER W, 1962, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V203, P560, DOI 10.1007/BF00343235

[3]

COSTA E, 1972, MONOAMINE OXIDASES N

[4] VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS [J].

EHRINGER, H ;

HORNYKIEWICZ, O .

KLINISCHE WOCHENSCHRIFT, 1960, 38 (24) :1236-1239

[5] THE CONTRIBUTION OF AMPHETAMINE METABOLITES OF (-)-DEPRENYL TO ITS ANTIPARKINSONIAN PROPERTIES [J].

ELSWORTH, JD ;

SANDLER, M ;

LEES, AJ ;

WARD, C ;

STERN, GM .

JOURNAL OF NEURAL TRANSMISSION, 1982, 54 (1-2) :105-110

[6] MONOAMINE OXIDASE INHIBITORS AND L-DOPA [J].

HUNTER, KR ;

BOAKES, AJ ;

LAURENCE, DR ;

STERN, GM .

BRITISH MEDICAL JOURNAL, 1970, 3 (5719) :388-&

[7] SOME OBSERVATIONS UPON A NEW INHIBITOR OF MONOAMINE OXIDASE IN BRAIN TISSUE [J].

JOHNSTON, JP .

BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1285-&

[8]

KNOLL J, 1978, BIOCHEM PHARMACOL, V27, P1739, DOI 10.1016/0006-2952(78)90550-6

[9]

LEES AJ, 1977, LANCET, V2, P791

[10]

PARKES JD, 1975, J NEUROL NEUROSUR PS, V38, P232, DOI 10.1136/jnnp.38.3.232

← 1 2 →